Ultragenyx Pharmaceutical (RARE) Market Cap 2014–2026

As of October 29, 2026, Ultragenyx Pharmaceutical had a market cap of $1.649 billion, which decreased by 2.48% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Ultragenyx Pharmaceutical logo

Ultragenyx Pharmaceutical Inc. (RARE)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$1.649B ▼ 2.48%
Start of 2026
$2.219B ▼ 25.69%
1 Year Ago
$3.389B ▼ 51.34%
All-Time High
$11.736B ▼ 85.95%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Ultragenyx Pharmaceutical Market Cap History by Year and Month

Ultragenyx Pharmaceutical Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$1.649B▼ 25.69%
$1.649B▲ 11.65%
$1.477B▼ 40.40%
$2.478B▲ 1.52%
$2.441B▼ 25.40%
$3.272B▲ 38.76%
$2.358B▼ 1.17%
$2.386B▲ 17.89%
$2.024B▼ 10.44%
$2.26B▼ 2.67%
$2.322B▲ 4.64%
2025$2.219B▼ 42.97%
2024$3.891B▼ 0.92%
2023$3.927B▲ 20.91%
2022$3.248B▼ 44.30%
All market cap values reflect closing prices for the period shown.

📊 Ultragenyx Pharmaceutical Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $12.85B
  2. $11.13B
  3. $10.21B
  4. $10.15B
  5. $9.97B
  6. $9.61B
  7. $9.34B
  8. $9.07B
  9. $8.79B
  10. $8.54B
  11. $8.06B
  12. $7.35B
  13. $7.1B
  14. $6.41B
  15. $5.49B
  16. $5.37B
  17. $5.25B
  18. $3.43B
  19. $2.03B
  20. $1.65B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.